Salcaprozate Impurity 3
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

287935-37-9Salcaprozate Impurity 3

● In Stock

Catalogue No.:VE0023559
CAS No.:287935-37-9
Mol. Formula:C18H23NO5
Mol. Weight:333.4 g/mol

Additional information on CAS 287935-37-9

Parent drug

Salcaprozate

IUPAC Name

Ethyl 8-(2, 4-dioxo-2H-benzo[e][1, 3]oxazin-3(4H)-yl)octanoate

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(OCC)CCCCCCCN1C(OC2=CC=CC=C2C1=O)=O

InChI

InChI=1S/C18H23NO5/c1-2-23-16(20)12-6-4-3-5-9-13-19-17(21)14-10-7-8-11-15(14)24-18(19)22/h7-8, 10-11H, 2-6, 9, 12-13H2, 1H3

Description

The Salcaprozate Impurity 3 standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Salcaprozate. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes. To further support research and development | it comes with a comprehensive Structure Elucidation Report (SER) | providing detailed insights for advanced analysis.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url